Probiotic-induced changes in the intestinal epithelium: implications in gastrointestinal disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 19760989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adhesion properties of Lactobacillus casei strains to resected intestinal fragments and components of the extracellular matrix

  2009cited by this paper
• Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.

  2009cited by this paper
• A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

  2009cited by this paper
• Molecular detection of the ruminal bacterium, Butyrivibrio fibrisolvens, in feces from rural residents of southern India

  2009cited by this paper
• Effect of Vibrio cholerae on Chemokine Gene Expression in HT29 cells and its Modulation by Lactobacillus GG

  2009cited by this paper
• Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate

  2008cited by this paper
• Probiotics for induction of remission in Crohn's disease.

  2008cited by this paper
• Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.

  2008cited by this paper
• Lactobacillus reuteri 100-23 transiently activates intestinal epithelial cells of mice that have a complex microbiota during early stages of colonization.

  2008cited by this paper
• Antibiotic-associated diarrhea: epidemiology, trends and treatment.

  2008cited by this paper
• A Meta-Analysis on the Efficacy of Probiotics for Maintenance of Remission and Prevention of Clinical and Endoscopic Relapse in Crohn’s Disease

  2008cited by this paper
• Therapeutic Potential of Two Probiotics in Inflammatory Bowel Disease as observed in the Trinitrobenzene Sulfonic Acid Model of Colitis

  2008cited by this paper
• Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function.

  2008cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• Mechanisms of infectious diarrhea

  2008cited by this paper
• Bacterial succession in the colon during childhood and adolescence: molecular studies in a southern Indian village.

  2008cited by this paper
• On the Benefit of Probiotics in the Management of Pouchitis in Patients Underwent Ileal Pouch Anal Anastomosis: A Meta-analysis of Controlled Clinical Trials

  2008cited by this paper
• The Efficacy of Probiotics in the Therapy of Irritable Bowel Syndrome (IBS): a Systematic Review

  2008cited by this paper
• Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve.

  2008cited by this paper
• Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism.

  2008cited by this paper
• An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy

  2008cited by this paper
• Control of acute, chronic, and constitutive hyperammonemia by wild‐type and genetically engineered Lactobacillus plantarum in rodents

  2008cited by this paper
• Overview of gut immunology.

  2008cited by this paper
• Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy

  2008cited by this paper
• Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells.

  2008cited by this paper
• The innate immune system of mammals and insects.

  2008cited by this paper
• The pathogenic role of intestinal flora in IBD and colon cancer.

  2008cited by this paper
• Lactobacillus rhamnosus Strain GG Prevents Enterohemorrhagic Escherichia coli O157:H7-Induced Changes in Epithelial Barrier Function

  2008cited by this paper
• Meta-analysis of probiotics for the treatment of irritable bowel syndrome.

  2008cited by this paper
• Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression.

  2008cited by this paper
• Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials

  2008cited by this paper
• Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response.

  2007cited by this paper
• The application of probiotics in cancer

  2007cited by this paper
• The Normal Bacterial Flora of the Human Intestine and Its Regulation

  2007cited by this paper
• The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells.

  2007cited by this paper
• Secreted Probiotic Factors Ameliorate Enteropathogenic Infection in Zinc-Deficient Human Caco-2 and T84 Cell Lines

  2007cited by this paper
• Probiotics and remission of ulcerative colitis: a systematic review.

  2007cited by this paper
• Protection of the Neonate by the Innate Immune System of Developing Gut and of Human Milk

  2007cited by this paper
• The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized study

  2007cited by this paper
• Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells.

  2007cited by this paper
• Review article: the evidence base for interventions used to maintain remission in Crohn’s disease

  2007cited by this paper
• Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair

  2007cited by this paper
• Probiotics for induction of remission in ulcerative colitis.

  2007cited by this paper
• Toll-like receptors and innate immunity in gut homeostasis and pathology

  2007cited by this paper
• Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.

  2007cited by this paper
• Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials.

  2006cited by this paper
• Anti-Inflammatory Effect of Lactobacillus casei on Shigella-Infected Human Intestinal Epithelial Cells1

  2006cited by this paper
• Lactic acid bacteria as probiotics.

  2006cited by this paper
• Probiotics, prebiotics and synbiotics: A role in chemoprevention for colorectal cancer?

  2006cited by this paper
• Specific Probiotics in Enhancing Maturation of IgA Responses in Formula-Fed Infants

  2006cited by this paper
• Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius

  2006cited by this paper
• Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway.

  2006cited by this paper
• Structural Shifts of Mucosa-Associated Lactobacilli and Clostridium leptum Subgroup in Patients with Ulcerative Colitis

  2006cited by this paper
• Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis

  2006cited by this paper
• Probiotics for maintenance of remission in Crohn's disease.

  2006cited by this paper
• Homeostatic Effects of TLR9 Signaling in Experimental Colitis

  2006cited by this paper
• Effect of lactulose and Saccharomyces boulardii administration on the colonic urea‐nitrogen metabolism and the bifidobacteria concentration in healthy human subjects

  2006cited by this paper
• Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial.

  2006cited by this paper
• Human defensins in Crohn's disease.

  2005cited by this paper
• Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses.

  2005cited by this paper
• Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice.

  2005cited by this paper
• Effect of a Probiotic Infant Formula on Infections in Child Care Centers: Comparison of Two Probiotic Agents

  2005cited by this paper
• A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon.

  2005cited by this paper
• An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.

  2005cited by this paper
• Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study

  2005cited by this paper
• Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

  2004cited by this paper
• Functional modulation of enterocytes by gram-positive and gram-negative microorganisms.

  2004cited by this paper
• Genetic heterogeneity and functional properties of intestinal bifidobacteria

  2004cited by this paper
• Modulation of human dendritic cell phenotype and function by probiotic bacteria

  2004cited by this paper
• Bacterial Probiotic Modulation of Dendritic Cells

  2004cited by this paper
• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

  2004cited by this paper
• The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002.

  2003cited by this paper
• Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance

  2003cited by this paper
• Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro

  2003cited by this paper
• Probiotics for treating infectious diarrhoea.

  2003cited by this paper
• Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent–invasive E. coli strains isolated from patients with Crohn's disease

  2003cited by this paper
• Toll-like Receptor Signaling*

  2003cited by this paper
• Influences of probiotic bacteria on organic acid production by pig caecal bacteria in vitro

  2003cited by this paper
• Variable Response to Probiotics in Two Models of Experimental Colitis in Rats

  2002cited by this paper
• Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA.

  2002cited by this paper
• Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IkappaB kinase activation.

  2002cited by this paper
• Effects of butyrate on active sodium and chloride transport in rat and rabbit distal colon

  2002cited by this paper
• Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria

  2002cited by this paper
• Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells1

  2002cited by this paper
• Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model

  2002cited by this paper
• Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice

  2002cited by this paper
• Protective role of probiotics and prebiotics in colon cancer.

  2001cited by this paper
• Probiotic bacteria enhance murine and human intestinal epithelial barrier function.

  2001cited by this paper
• Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks.

  2001cited by this paper
• Differential Interleukin-8 Response of Intestinal Epithelial Cell Line to Reactogenic and Nonreactogenic Candidate Vaccine Strains of Vibrio cholerae

  2001cited by this paper
• Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surfa

  2001cited by this paper
• Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria.

  2000cited by this paper
• Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate.

  2000cited by this paper
• Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity

  2000cited by this paper
• Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.

  1999cited by this paper
• Butyrate hastens restoration of barrier function after thermal and detergent injury to rat distal colon in vitro.

  1999cited by this paper
• Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

  1999cited by this paper
• T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

  1999cited by this paper
• Production and oxidation of short-chain fatty acids in the human colon: implications for antibiotic-associated diarrhea, ulcerative colitis, colonic cancer, and hepatic encephalopathy.

  1998cited by this paper
• Sulfides impair short chain fatty acid β-oxidation at acyl-CoA dehydrogenase level in colonocytes: Implications for ulcerative colitis

  1998cited by this paper

• Strain-Specific Benefits of Bacillus Probiotics in Hybrid Grouper: Growth Enhancement, Metabolic Health, Immune Modulation, and Vibrio harveyi Resistance

  2024cites this paper
• In Vitro Effects of Postmetabolites from Limosilactobacillus fermentum 53 on the Survival and Proliferation of HT-29 Cells

  2024cites this paper
• Beneficial insights into postbiotics against colorectal cancer

  2023cites this paper
• Diversity, distribution and role of probiotics for human health: Current research and future challenges

  2023cites this paper
• Bioaccessibility and Bioavailability of Diet Polyphenols and Their Modulation of Gut Microbiota

  2023cites this paper
• Faecal microbiota transplantation is better than probiotics for tissue regeneration of type 2 diabetes mellitus injuries in mice

  2022cites this paper
• Lactobacillus rhamnosus CY12 Enhances Intestinal Barrier Function by Regulating Tight Junction Protein Expression, Oxidative Stress, and Inflammation Response in Lipopolysaccharide-Induced Caco-2 Cells

  2022cites this paper
• Use of Probiotic Bacteria and Bacteriocins as an Alternative to Antibiotics in Aquaculture

  2022cites this paper
• The function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis: a systematic review

  2021cites this paper
• Identification of Lactobacillus Strains Capable of Fermenting Fructo-Oligosaccharides and Inulin

  2021cites this paper
• Enhancement of intestinal epithelial barrier function by Weissella confusa F213 and Lactobacillus rhamnosus FBB81 probiotic candidates in an in vitro model of hydrogen peroxide-induced inflammatory bowel disease

  2020cites this paper
• The Gut Microbiome: Human Health and Inflammatory Skin Diseases

  2020cites this paper
• Probiotics From Food Products and Gastrointestinal Health

  2019cites this paper
• Halophilic bacteria as a potential management for autism

  2019cites this paper
• Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome

  2019cites this paper
• Strain-level diversity of commercial probiotic isolates of Bacillus, Lactobacillus, and Saccharomyces species illustrated by molecular identification and phenotypic profiling

  2019cites this paper
• Zinc alleviates arsenism in common carp: Varied change profiles of cytokines and tight junction proteins among two intestinal segments.

  2019cites this paper
• Intestinal Bacterial Flora and Alzheimer’s Disease

  2018cites this paper
• Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial

  2018cites this paper
• Rhapontin ameliorates colonic epithelial dysfunction in experimental colitis through SIRT1 signaling

  2017cites this paper
• Butyrate protects against disruption of the blood‐milk barrier and moderates inflammatory responses in a model of mastitis induced by lipopolysaccharide

  2017cites this paper
• Probiotic Bacteria and their Supernatants Protect Enterocyte Cell Lines from Enteroinvasive Escherichia coli (EIEC) Invasion

  2017cites this paper
• Oral administration of yeast β-glucan ameliorates inflammation and intestinal barrier in dextran sodium sulfate-induced acute colitis

  2017cites this paper
• Role of nanotechnology in enhancing bioavailability and delivery of dietary factors

  2017cites this paper
• Nicotinic modulation in TNBS-induced colitis: focus on spleen and T-cells

  2017cites this paper
• Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease

  2016cites this paper
• Dietary Fermentable Fiber Reduces Intestinal Barrier Defects and Inflammation in Colitic Mice 1–3

  2016cites this paper
• Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease: Rationale and Current Evidence.

  2016cites this paper
• Dietary Fermentable Fiber Reduces Intestinal Barrier Defects and Inflammation in Colitic Mice.

  2016cites this paper
• Specific probiotics in the upper respiratory tract: colonization, efficacy and safety : with a focus on Lactobacillus rhamnosus GG

  2016cites this paper
• Porcine lactoferrin-derived peptide LFP-20 protects intestinal barrier by maintaining tight junction complex and modulating inflammatory response.

  2016influential citation
• Probiotics and the Upper Respiratory Tract - A Review

  2016cites this paper
• Cellular and molecular mechanisms of probiotics effects on colorectal cancer

  2015cites this paper
• Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis

  2015cites this paper
• Immunomodulatory Effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, Alone and in Combination, on Peripheral Blood Mononuclear Cells of Allergic Asthmatics

  2015cites this paper
• Porcine β-Defensin 2 Attenuates Inflammation and Mucosal Lesions in Dextran Sodium Sulfate–Induced Colitis

  2015influential citation
• Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.

  2015cites this paper
• Immunomodulatory properties of the human intestinal microbiota and prospects for the use of probiotics for prophylaxis and correction of inflammatory processes

  2015cites this paper
• Intestinal ecological floral imbalance and irritable bowel syndrome

  2015cites this paper
• Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial.

  2014cites this paper
• Effect of Bacillus amyloliquefaciens-based direct-fed microbials and antibiotic on performance, nutrient digestibility, cecal microflora, and intestinal morphology in broiler chickens

  2014cites this paper
• Infectious Microecology in Immunodeficiency Diseases

  2014cites this paper
• Probiotics: immunomodulatory properties in allergy and eczema.

  2013cites this paper
• Los probióticos: ¿cómo una mezcla de microorganismos hacen un gran trabajo?

  2012cites this paper
• Type 2 cGMP-dependent protein kinase regulates proliferation and differentiation in the colonic mucosa.

  2012influential citation
• Type 2 cGMP-Dependent Protein Kinase Regulates Proliferation and Differentiation in the 5 Colonic Mucosa 6 7 8 ( Running title : PKG 2 regulates colon homeostasis ) 9 10 11

  2012influential citation
• Protective role of 1,25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice

  2012influential citation
• Probiotics Reduce Gut Microbial Translocation and Improve Adult Atopic Dermatitis

  2012cites this paper
• The probiotics: how a mixture of microorganisms do a great job?

  2012cites this paper
• Changing of Fecal Flora and Clinical Effect of L. salivarius LS01 in Adults With Atopic Dermatitis

  2012cites this paper
• Influence of Natural and Synthetic Histone Deacetylase Inhibitors on Chromatin

  2012cites this paper
• Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management.

  2011cites this paper
• The design of probiotic studies to substantiate health claims.

  2011cites this paper
• Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

  2011cites this paper
• Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis

  2011cites this paper
• Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.

  2010cites this paper
• Nutritional Protocol for the Treatment of Intestinal Permeability Defects and Related Conditions

  2010cites this paper
• The role of probiotics and prebiotics in apoptosis of the gastrointestinal tract

  2010cites this paper
• Encapsulation for preservation of functionality and targeted delivery of bioactive food components

  2010cites this paper